{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-015198","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2024-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.757591+00:00","generated_at":"2026-06-03T19:07:42.280853+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"INBS preliminary Q3 revenue $0.82M, up 80% YoY; nine-month revenue $2.38M, up 193%","bullets":["Preliminary unaudited revenue $0.82M for fiscal Q3 ended March 31, 2024, up 80% vs. prior year.","Nine-month revenue $2.38M, up 193% YoY.","Cartridge sales up 17% and reader sales up 20% in Q3; highest quarterly cartridge sales since 2022 acquisition.","Nine-month cartridge sales up 25%, reader sales up 63% YoY.","Full financial results expected in Form 10-Q filed during week of May 6, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-015198","json":"https://secwatch.observer/filing/0001493152-24-015198.json","markdown":"https://secwatch.observer/filing/0001493152-24-015198.md","text":"https://secwatch.observer/filing/0001493152-24-015198.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224015198/0001493152-24-015198-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224015198/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T19:07:42.280853+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2f076323ea9054e4589a5b1b5ea0ac0bff2db06e","claim":"INTELLIGENT BIO SOLUTIONS INC. reported the fiscal third quarter and nine months ended March 31, 2024 results: revenue $0.82 million.","evidence_excerpt":"today announced preliminary unaudited revenue results for the fiscal third quarter and nine months ended March 31, 2024. The Company expects approximate unaudited revenue of $0.82 million for the three months ended March 31, 2024, representing an increase of 80% compared to the same period the prior year, and approximate unaudited revenue of $2.38 million for the","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224015198/0001493152-24-015198-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal third quarter and nine months ended March 31, 2024"},{"label":"Revenue","value":"$0.82 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}